Jing Chen

Jing Chen is an accomplished professional with extensive experience in drug metabolism and pharmacokinetics (DMPK) within the biopharmaceutical industry. Currently serving as Director of Discovery DMPK at Arrowhead Pharmaceuticals since April 2017, Jing has successfully led teams in conducting in vitro and in vivo metabolic identification studies and advancing DMPK understanding for new oligonucleotide platforms. Prior roles included Associate Director and Senior Chemist positions at Arrowhead, where Jing developed critical in-house capabilities for oligonucleotide quantitation and metabolism identification. Previously, as an LC-MS Scientist at Agilent Technologies, Jing led the development of assays for antibody-drug conjugate characterization. Academic experience includes a Postdoctoral Research Fellowship at Johns Hopkins University, focusing on mass spectrometry and biomarker identification, and a Research Assistant role at the University of Washington. Jing holds a Ph.D. and an MS in Toxicology from the University of Washington.